Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism

In cancer patients treated for venous thromboembolism (VTE), including deep-vein thrombosis (DVT) and pulmonary embolism (PE), analyzing mortality associated with recurrent VTE or major bleeding is needed to determine the optimal duration of anticoagulation. This was a cohort study using the Registr...

Descripción completa

Detalles Bibliográficos
Autores principales: Farge, Dominique, Trujillo-Santos, Javier, Debourdeau, Philippe, Bura-Riviere, Alessandra, Rodriguez-Beltrán, Eva Maria, Nieto, Jose Antonio, Peris, Maria Luisa, Zeltser, David, Mazzolai, Lucia, Hij, Adrian, Monreal, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616675/
https://www.ncbi.nlm.nih.gov/pubmed/26266353
http://dx.doi.org/10.1097/MD.0000000000001235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616675/
https://www.ncbi.nlm.nih.gov/pubmed/26266353
http://dx.doi.org/10.1097/MD.0000000000001235

Ejemplares similares